Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ironwood Pharmaceuticals Inc (IRWD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ironwood Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1446847.
Total stock buying since 2015: $23,429,816.
Total stock sales since 2015: $62,104,157.
Total stock option exercises since 2015: $19,222,669.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 259,115 | $440,886 | 0 | $0 |
| 2024 | 17,604 | $160,418 | 536,935 | $5,863,374 | 0 | $0 |
| 2023 | 36,072 | $300,119 | 624,085 | $7,224,142 | 332,886 | $3,878,121 |
| 2022 | 0 | $0 | 581,591 | $6,752,594 | 208,424 | $2,428,138 |
| 2021 | 2,365,000 | $22,969,279 | 284,297 | $3,055,230 | 0 | $0 |
| 2020 | 0 | $0 | 277,980 | $3,254,706 | 258,076 | $2,511,317 |
| 2019 | 0 | $0 | 652,884 | $7,613,387 | 370,449 | $1,809,094 |
| 2018 | 0 | $0 | 579,710 | $10,369,251 | 547,852 | $4,061,750 |
| 2017 | 0 | $0 | 362,736 | $5,987,975 | 458,372 | $1,647,166 |
| 2016 | 0 | $0 | 315,282 | $3,546,799 | 855,655 | $1,814,523 |
| 2015 | 0 | $0 | 536,505 | $7,995,813 | 803,223 | $1,072,560 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 13,181 | $11,070 | 0 | $0 |
| 2025-05 | 0 | $0 | 2,563 | $1,486 | 0 | $0 |
| 2025-02 | 0 | $0 | 243,371 | $428,330 | 0 | $0 |
| 2024-11 | 0 | $0 | 16,361 | $66,752 | 0 | $0 |
| 2024-08 | 0 | $0 | 13,017 | $55,581 | 0 | $0 |
| 2024-06 | 0 | $0 | 102,766 | $660,891 | 0 | $0 |
| 2024-05 | 0 | $0 | 123,875 | $798,992 | 0 | $0 |
| 2024-03 | 17,604 | $160,418 | 0 | $0 | 0 | $0 |
| 2024-02 | 0 | $0 | 280,916 | $4,281,158 | 0 | $0 |
| 2023-12 | 0 | $0 | 9,926 | $111,071 | 0 | $0 |
| 2023-11 | 0 | $0 | 3,287 | $31,851 | 0 | $0 |
| 2023-09 | 36,072 | $300,119 | 0 | $0 | 0 | $0 |
| 2023-08 | 0 | $0 | 9,021 | $90,570 | 0 | $0 |
| 2023-05 | 0 | $0 | 58,104 | $614,031 | 0 | $0 |
| 2023-03 | 0 | $0 | 79,885 | $870,938 | 0 | $0 |
| 2023-02 | 0 | $0 | 130,976 | $1,487,748 | 0 | $0 |
| 2023-01 | 0 | $0 | 332,886 | $4,017,933 | 332,886 | $3,878,121 |
| 2022-11 | 0 | $0 | 31,785 | $367,428 | 0 | $0 |
| 2022-08 | 0 | $0 | 151,044 | $1,763,364 | 18,041 | $210,177 |
| 2022-06 | 0 | $0 | 217,952 | $2,606,280 | 190,383 | $2,217,961 |
| 2022-05 | 0 | $0 | 60,548 | $696,301 | 0 | $0 |
| 2022-03 | 0 | $0 | 23,031 | $272,045 | 0 | $0 |
| 2022-02 | 0 | $0 | 97,231 | $1,047,176 | 0 | $0 |
| 2021-12 | 0 | $0 | 83,327 | $943,351 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-11 | Gaskins Tammi L (Chief Commercial Officer) | Sale | 1,316 | .84 | 1,105 |
| 2025-08-11 | Martini Gregory S. (Chief Financial Officer) | Sale | 1,265 | .84 | 1,062 |
| 2025-08-11 | John Minardo (Chief Legal Officer) | Sale | 7,754 | .84 | 6,513 |
| 2025-08-11 | Silver Ronald (Principal Accounting Officer) | Sale | 2,846 | .84 | 2,390 |
| 2025-05-16 | Gaskins Tammi L (Chief Commercial Officer) | Sale | 2,563 | .58 | 1,486 |
| 2025-02-10 | Martini Gregory S. (Chief Financial Officer) | Sale | 12,052 | 1.76 | 21,211 |
| 2025-02-10 | John Minardo (Chief Legal Officer) | Sale | 38,938 | 1.76 | 68,530 |
| 2025-02-10 | Silver Ronald (Principal Accounting Officer) | Sale | 12,048 | 1.76 | 21,204 |
| 2025-02-10 | Shetzline Michael (SVP, CMO, Head-Res&Drug) | Sale | 41,269 | 1.76 | 72,633 |
| 2025-02-10 | Mccourt Thomas A (Chief Executive Officer) | Sale | 139,064 | 1.76 | 244,752 |
| 2024-11-18 | Davis Andrew (SVP, Chief Business Officer) | Sale | 5,360 | 4.08 | 21,868 |
| 2024-11-18 | Emany Sravan Kumar (SVP, COO and CFO) | Sale | 11,001 | 4.08 | 44,884 |
| 2024-08-12 | John Minardo (Chief Legal Officer) | Sale | 9,910 | 4.27 | 42,315 |
| 2024-08-12 | Silver Ronald (Principal Accounting Officer) | Sale | 3,107 | 4.27 | 13,266 |
| 2024-06-10 | Mchugh Julie | Sale | 22,766 | 6.29 | 143,198 |
| 2024-06-07 | Moukheibir Catherine | Sale | 35,574 | 6.61 | 235,144 |
| 2024-06-06 | Moukheibir Catherine | Sale | 44,426 | 6.36 | 282,549 |
| 2024-05-20 | Davis Andrew (SVP, Chief Business Officer) | Sale | 22,725 | 6.45 | 146,576 |
| 2024-05-20 | John Minardo (Chief Legal Officer) | Sale | 17,404 | 6.45 | 112,255 |
| 2024-05-20 | Shetzline Michael (CMO,SVP,Head-Res&Drug) | Sale | 16,128 | 6.45 | 104,025 |
| 2024-05-20 | Mccourt Thomas A (Chief Executive Officer) | Sale | 67,618 | 6.45 | 436,136 |
| 2024-03-06 | Duane Jon R | Buy | 6,920 | 8.70 | 60,203 |
| 2024-03-04 | Emany Sravan Kumar (SVP, Chief Financial Officer) | Buy | 10,684 | 9.38 | 100,215 |
| 2024-02-12 | Davis Andrew (SVP, Chief Business Officer) | Sale | 9,846 | 15.24 | 150,053 |
| 2024-02-12 | John Minardo (Chief Legal Officer) | Sale | 47,380 | 15.24 | 722,071 |
| 2024-02-12 | Silver Ronald (Principal Accounting Officer) | Sale | 7,908 | 15.24 | 120,517 |
| 2024-02-12 | Shetzline Michael (CMO,SVP,Head-Res&Drug) | Sale | 38,618 | 15.24 | 588,538 |
| 2024-02-12 | Mccourt Thomas A (Chief Executive Officer) | Sale | 177,164 | 15.24 | 2,699,979 |
| 2023-12-14 | Kessler Marla L (Director) | Sale | 9,926 | 11.19 | 111,071 |
| 2023-11-20 | Davis Andrew (SVP, Chief Business Officer) | Sale | 3,287 | 9.69 | 31,851 |
| 2023-09-15 | Emany Sravan Kumar (SVP, Chief Financial Officer) | Buy | 36,072 | 8.32 | 300,119 |
| 2023-08-14 | John Minardo (Chief Legal Officer) | Sale | 7,045 | 10.04 | 70,731 |
| 2023-08-14 | Silver Ronald (Principal Accounting Officer) | Sale | 1,976 | 10.04 | 19,839 |
| 2023-05-30 | Mccourt Thomas A (Chief Executive Officer) | Sale | 26,632 | 10.70 | 284,962 |
| 2023-05-22 | Shetzline Michael (CMO,SVP,Head-Res&Drug) | Sale | 10,324 | 10.12 | 104,478 |
| 2023-05-08 | Mccourt Thomas A (Chief Executive Officer) | Sale | 21,148 | 10.62 | 224,591 |
| 2023-03-27 | Mccourt Thomas A (Chief Executive Officer) | Sale | 46,129 | 10.67 | 492,196 |
| 2023-03-03 | Mccourt Thomas A (Chief Executive Officer) | Sale | 33,756 | 11.22 | 378,742 |
| 2023-02-28 | Davis Andrew (SVP, Chief Business Officer) | Sale | 1,822 | 11.31 | 20,606 |
| 2023-02-28 | John Minardo (Chief Legal Officer) | Sale | 3,415 | 11.31 | 38,623 |
| 2023-02-28 | Silver Ronald (Principal Accounting Officer) | Sale | 3,049 | 11.31 | 34,484 |
| 2023-02-28 | Shetzline Michael (CMO,SVP,Head-Res&Drug) | Sale | 9,854 | 11.31 | 111,448 |
| 2023-02-28 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 17,429 | 11.31 | 197,121 |
| 2023-02-28 | Mccourt Thomas A (Chief Executive Officer) | Sale | 31,227 | 11.31 | 353,177 |
| 2023-02-27 | Davis Andrew (SVP, Chief Business Officer) | Sale | 1,751 | 11.41 | 19,978 |
| 2023-02-27 | John Minardo (Chief Legal Officer) | Sale | 3,282 | 11.41 | 37,447 |
| 2023-02-27 | Silver Ronald (Principal Accounting Officer) | Sale | 2,929 | 11.41 | 33,419 |
| 2023-02-27 | Shetzline Michael (CMO,SVP,Head-Res&Drug) | Sale | 9,468 | 11.41 | 108,029 |
| 2023-02-27 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 16,746 | 11.41 | 191,071 |
| 2023-02-27 | Mccourt Thomas A (Chief Executive Officer) | Sale | 30,004 | 11.41 | 342,345 |
| 2023-01-05 | Mccourt Thomas A (Chief Executive Officer) | Sale | 221,924 | 12.07 | 2,678,622 |
| 2023-01-05 | Mccourt Thomas A (Chief Executive Officer) | Option Ex | 221,924 | 11.65 | 2,585,414 |
| 2022-11-21 | Davis Andrew (SVP, Chief Business Officer) | Sale | 6,670 | 11.56 | 77,104 |
| 2022-11-21 | Emany Sravan Kumar (SVP, Chief Financial Officer) | Sale | 13,156 | 11.56 | 152,082 |
| 2022-11-21 | Silver Ronald (Principal Accounting Officer) | Sale | 1,364 | 11.56 | 15,766 |
| 2022-08-15 | John Minardo (Chief Legal Officer) | Sale | 7,330 | 11.77 | 86,274 |
| 2022-08-15 | Silver Ronald (Principal Accounting Officer) | Sale | 2,014 | 11.77 | 23,704 |
| 2022-08-15 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 994 | 11.77 | 11,699 |
| 2022-08-11 | Currie Mark G (Director) | Sale | 70,000 | 11.78 | 824,600 |
| 2022-08-09 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 18,041 | 11.75 | 211,981 |
| 2022-08-09 | Rickard Jason (SVP, Chief Operating Officer) | Option Ex | 18,041 | 11.65 | 210,177 |
| 2022-08-08 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 29,436 | 11.60 | 341,457 |
| 2022-08-01 | Mccourt Thomas A (Chief Executive Officer) | Sale | 23,229 | 11.35 | 263,649 |
| 2022-06-30 | Mccourt Thomas A (Chief Executive Officer) | Sale | 19,959 | 11.58 | 231,125 |
| 2022-06-14 | Kessler Marla L (Director) | Sale | 7,610 | 11.65 | 88,656 |
| 2022-06-07 | Currie Mark G (Director) | Sale | 190,383 | 12.01 | 2,286,499 |
| 2022-06-07 | Currie Mark G (Director) | Option Ex | 190,383 | 11.65 | 2,217,961 |
| 2022-05-23 | Silver Ronald (Principal Accounting Officer) | Sale | 120 | 11.50 | 1,380 |
| 2022-05-23 | Shetzline Michael (CMO,SVP,Head-Res&Drug) | Sale | 10,583 | 11.50 | 121,704 |
| 2022-05-23 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 13,537 | 11.50 | 155,675 |
| 2022-05-23 | Mccourt Thomas A (Chief Executive Officer) | Sale | 36,308 | 11.50 | 417,542 |
| 2022-03-24 | Silver Ronald (Principal Accounting Officer) | Sale | 3,031 | 12.75 | 38,645 |
| 2022-03-14 | Mchugh Julie (Director) | Sale | 20,000 | 11.67 | 233,400 |
| 2022-02-28 | Silver Ronald (Principal Accounting Officer) | Sale | 2,238 | 10.77 | 24,103 |
| 2022-02-28 | Shetzline Michael (CMO,SVP,Head-Res&Drug) | Sale | 17,607 | 10.77 | 189,627 |
| 2022-02-28 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 28,962 | 10.77 | 311,920 |
| 2022-02-28 | Mccourt Thomas A (Chief Executive Officer) | Sale | 48,424 | 10.77 | 521,526 |
| 2021-12-22 | Mccourt Thomas A (Chief Executive Officer) | Sale | 46,327 | 11.41 | 528,591 |
| 2021-12-16 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 27,000 | 11.28 | 304,560 |
| 2021-12-14 | Mchugh Julie (Director) | Sale | 10,000 | 11.02 | 110,200 |
| 2021-11-23 | Silver Ronald (Principal Accounting Officer) | Sale | 1,462 | 11.58 | 16,929 |
| 2021-11-23 | Shetzline Michael (CMO,SVP,Head-Res&Drug) | Sale | 13,776 | 11.58 | 159,526 |
| 2021-11-23 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 17,193 | 11.58 | 199,094 |
| 2021-11-23 | Mccourt Thomas A (Chief Executive Officer) | Sale | 52,644 | 11.58 | 609,617 |
| 2021-08-16 | Silver Ronald (Principal Accounting Officer) | Sale | 567 | 13.48 | 7,643 |
| 2021-08-16 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 680 | 13.48 | 9,166 |
| 2021-06-14 | Currie Mark G (Director) | Sale | 23,571 | 11.59 | 273,187 |
| 2021-05-24 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 516 | 12.25 | 6,321 |
| 2021-05-24 | Mccourt Thomas A (President and Interim CEO) | Sale | 1,716 | 12.25 | 21,021 |
| 2021-03-10 | Sarissa Capital Management Lp | Buy | 75,000 | 10.54 | 790,499 |
| 2021-03-08 | Sarissa Capital Management Lp | Buy | 150,000 | 10.30 | 1,545,000 |
| 2021-03-05 | Sarissa Capital Management Lp | Buy | 175,000 | 10.01 | 1,751,750 |
| 2021-03-04 | Sarissa Capital Management Lp | Buy | 250,000 | 10.00 | 2,500,000 |
| 2021-03-03 | Sarissa Capital Management Lp | Buy | 350,000 | 10.02 | 3,507,000 |
| 2021-03-02 | Denner Alexander J | Buy | 500,000 | 9.56 | 4,780,000 |
| 2021-03-01 | Denner Alexander J | Buy | 344,900 | 9.60 | 3,311,040 |
| 2021-02-26 | Kilroy Conor (SVP, GC & Secretary) | Sale | 6,989 | 9.11 | 63,669 |
| 2021-02-26 | Shetzline Michael (CMO, SVP & Head of Drug Devt.) | Sale | 4,439 | 9.11 | 40,439 |
| 2021-02-26 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 13,651 | 9.11 | 124,360 |
| 2021-02-26 | Mallon Mark (Chief Executive Officer) | Sale | 30,675 | 9.11 | 279,449 |
| 2021-02-26 | Owens Edward P (Director) | Buy | 3,000 | 8.90 | 26,700 |
| 2021-02-26 | Consylman Gina (SVP, CFO & Treasurer) | Sale | 18,406 | 9.11 | 167,678 |
| 2021-02-26 | Mccourt Thomas A (President) | Sale | 14,685 | 9.11 | 133,780 |
| 2021-02-26 | Denner Alexander J | Buy | 505,100 | 9.20 | 4,646,920 |
| 2021-02-25 | Owens Edward P (Director) | Buy | 5,000 | 9.11 | 45,550 |
| 2021-02-24 | Owens Edward P (Director) | Buy | 7,000 | 9.26 | 64,820 |
| 2020-12-14 | Mccourt Thomas A (President) | Option Ex | 99,988 | 9.89 | 988,881 |
| 2020-12-04 | Macdonald Kelly (Chief Accounting Officer) | Sale | 5,639 | 12.50 | 70,487 |
| 2020-12-04 | Macdonald Kelly (Chief Accounting Officer) | Option Ex | 5,639 | 9.12 | 51,427 |
| 2020-11-11 | Macdonald Kelly (Chief Accounting Officer) | Sale | 3,561 | 11.75 | 41,841 |
| 2020-11-11 | Macdonald Kelly (Chief Accounting Officer) | Option Ex | 3,561 | 9.31 | 33,152 |
| 2020-11-09 | Kilroy Conor (SVP, GC & Secretary) | Sale | 836 | 10.92 | 9,129 |
| 2020-11-09 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 394 | 10.92 | 4,302 |
| 2020-11-09 | Macdonald Kelly (Chief Accounting Officer) | Sale | 925 | 10.92 | 10,101 |
| 2020-11-09 | Consylman Gina (SVP, CFO & Treasurer) | Sale | 1,415 | 10.92 | 15,451 |
| 2020-11-06 | Macdonald Kelly (Chief Accounting Officer) | Sale | 1,872 | 11.25 | 21,060 |
| 2020-10-08 | Macdonald Kelly (Chief Accounting Officer) | Sale | 22,714 | 10.50 | 238,497 |
| 2020-09-08 | Mchugh Julie (Director) | Sale | 7,950 | 9.77 | 77,671 |
| 2020-08-17 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 689 | 10.14 | 6,986 |
| 2020-08-17 | Macdonald Kelly (Chief Accounting Officer) | Sale | 575 | 10.14 | 5,830 |
| 2020-06-10 | Olanoff Lawrence S (Director) | Sale | 11,350 | 10.06 | 114,181 |
| 2020-05-11 | Kilroy Conor (SVP, GC & Secretary) | Sale | 716 | 10.35 | 7,410 |
| 2020-05-11 | Rickard Jason (SVP, Chief Operating Officer) | Sale | 510 | 10.35 | 5,278 |
| 2020-05-11 | Macdonald Kelly (Chief Accounting Officer) | Sale | 1,153 | 10.35 | 11,933 |
| 2020-05-11 | Mallon Mark (Chief Executive Officer) | Sale | 23,206 | 10.35 | 240,182 |
| 2020-05-11 | Mccourt Thomas A (President) | Sale | 1,697 | 10.35 | 17,563 |
| 2020-02-24 | Mallon Mark (Chief Executive Officer) | Sale | 1 | 11.25 | 11 |
| 2020-02-21 | Macdonald Kelly (Chief Accounting Officer) | Sale | 3,900 | 11.63 | 45,357 |
| 2020-02-21 | Mallon Mark (Chief Executive Officer) | Sale | 7,983 | 11.63 | 92,842 |
| 2020-02-21 | Gilbert Halley E (Chief Admin Officer & SVP) | Sale | 15,328 | 11.63 | 178,264 |
| 2020-02-21 | Consylman Gina (SVP, CFO & Treasurer) | Sale | 12,501 | 11.63 | 145,386 |
| 2020-02-21 | Mccourt Thomas A (President) | Sale | 4,177 | 11.63 | 48,578 |
| 2020-01-31 | Gilbert Halley E (Chief Admin Officer & SVP) | Sale | 60,000 | 12.05 | 723,000 |
| 2020-01-31 | Gilbert Halley E (Chief Admin Officer & SVP) | Option Ex | 60,000 | 10.02 | 601,200 |
| 2020-01-24 | Mccourt Thomas A (President) | Sale | 20,000 | 12.71 | 254,200 |
| 2020-01-24 | Mccourt Thomas A (President) | Option Ex | 20,000 | 10.02 | 200,400 |
| 2020-01-23 | Currie Mark G (Director) | Sale | 60,000 | 12.59 | 755,400 |
| 2020-01-23 | Currie Mark G (Director) | Option Ex | 60,000 | 9.12 | 547,200 |
| 2020-01-16 | Currie Mark G (Director) | Sale | 8,888 | 12.80 | 113,766 |
| 2020-01-16 | Currie Mark G (Director) | Option Ex | 8,888 | 10.02 | 89,057 |
| 2019-11-08 | Macdonald Kelly (Chief Accounting Officer) | Sale | 987 | 11.00 | 10,857 |
| 2019-11-08 | Consylman Gina (SVP, CFO & Treasurer) | Sale | 1,510 | 11.00 | 16,610 |
| 2019-08-30 | Mccourt Thomas A (President) | Sale | 220,000 | 9.24 | 2,032,800 |
| 2019-08-30 | Mccourt Thomas A (President) | Option Ex | 220,000 | 4.88 | 1,073,600 |
| 2019-08-16 | Consylman Gina (SVP, CFO & Treasurer) | Sale | 212 | 9.04 | 1,916 |
| 2019-07-26 | Gilbert Halley E (Chief Admin Officer & SVP) | Sale | 20,000 | 10.00 | 200,000 |
| 2019-07-26 | Gilbert Halley E (Chief Admin Officer & SVP) | Option Ex | 20,000 | 4.88 | 97,600 |
| 2019-06-05 | Mchugh Julie (Director) | Sale | 1,500 | 11.26 | 16,890 |
| 2019-06-05 | Olanoff Lawrence S (Director) | Sale | 2,000 | 11.25 | 22,500 |
| 2019-05-10 | Gilbert Halley E (Chief Admin Officer & SVP) | Sale | 4,055 | 10.53 | 42,699 |
Insider trading activities including stock purchases, stock sales, and option exercises of IRWD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ironwood Pharmaceuticals Inc (symbol IRWD, CIK number 1446847) see the Securities and Exchange Commission (SEC) website.